Professor Chris P. Gale

Profile

I am a Professor of Cardiovascular Medicine, Honorary Consultant Cardiologist, and Co-Director of the Leeds Institute for Data Analytics at the University of Leeds.

Qualifying in medicine at the London Hospital Medical College and obtaining a BSc (Hons) in Psychology, I worked as a Junior Doctor at the Royal London Hospital. After becoming a Member of the Royal College of Physicians, I was awarded a Medical Research Council Clinical Training Fellowship and completed a Ph.D in molecular biology at the University of Leeds. I undertook specialty training in cardiology principally at the Leeds General Infirmary, where I was a Walport and later a NIHR Academic Clinical Lecturer, then achieving a NIHR Clinician Scientist Award, and subsequently NIHR Clinical Trials Fellowship. I hold a Masters in Clinical Education and a Masters in Biostatistics and Epidemiology.

Presently, I am Honorary Consultant Cardiologist at Leeds General Infirmary where I practice clinical cardiology with particular interests in general cardiology and chronic heart failure. In 2023 I was commissioned by the UK Public Inquiry into Covid-19 to serve as the Independent Expert for Cardiovascular Disease for the Impact of Covid-19 Pandemic on Healthcare Systems in the 4 Nations of the UK (Module 3). I Co-Chair The Lancet Regional Health – Europe Commission on Inequalities and Disparities in Cardiovascular Health.

I am a trialist and health services researcher. My research incorporates the use of observational and randomised data to deliver population-based studies of cardiovascular care and outcomes. I lead a research active group at the Leeds Institute for Cardiovascular and Metabolic Medicine, University of Leeds. I hold major research awards predominantly from the NIHR, British Heart Foundation and Horizon 2020. I have published over 375 research manuscripts in peer reviewed journals including JAMA, Lancet, BMJ, EHJ amounting to over 150,000 citations, with H index 100.

I am a Fellow of the Royal College of Physicians of London, Fellow of the European Society of Cardiology and member of the British Cardiovascular Society. I am Clinical Lead for the UK nationwide heart attack register (Myocardial Ischaemia National Audit Project, MINAP), the largest continuous collection register of heart attacks in the world which is used to inform care quality in the NHS. I am Section Editor for the ESC Textbook of Cardiovascular Disease.

I hold leadership positions which harmonise with my clinical and academic interests, including Executive Committee member of EuroHeart and immediate past Chair of the European Society of Cardiology Quality Indicator Committee. I have recently completed a 10-year term as member of the NICE Indicator Advisory Committee. I Chair a number of Data Monitoring Committees for Randomised Clinical Trials.

Responsibilities

• Co-Director of the Leeds Institute for Data Analytics

Research interests

Ramdomised clinical trails; Health services research; Epidemiology, focussing on acute coronary syndrome, heart failure and atraial fibrillation.

Qualifications

• BSc (Hons), MB;BS, Ph.D, MEd, MSc, FESC, FRCP

Professional memberships

• Fellow of the Royal College of Physicians of London
• Fellow of the European Society of Cardiology
• British Cardiovascular Society

Research groups and institutes

• Leeds Institute of Cardiovascular and Metabolic Medicine
• Clinical and Population Science
• British Heart Foundation - Cardiovascular research
• Populations
• Multidisciplinary Cardiovascular Research Centre

Current postgraduate researchers

• Owen Bebb
• Dr Chris Wilkinson

Projects

<li><a href="//phd.leeds.ac.uk/project/150-licamm-a-machine-learning-approach-to-understand-the-disease-trajectories-of-atrial-fibrillation.">LICAMM A machine learning approach to understand the disease trajectories of atrial fibrillation.</a></li> <li><a href="//phd.leeds.ac.uk/project/145-licamm-medication-adherence,-compliance,-satisfaction-and-health-related-quality-of-life-after-myocardial-infarction:-emmace-3-and-4-trials">LICAMM Medication adherence, compliance, satisfaction and health related quality of life after myocardial infarction: EMMACE 3 and 4 trials</a></li>